Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1991 3
1992 3
1993 4
1994 3
1995 8
1996 6
1997 7
1998 5
1999 4
2000 7
2001 4
2002 8
2003 8
2004 7
2005 5
2006 2
2007 3
2008 8
2009 3
2010 7
2011 1
2012 3
2013 5
2014 6
2015 2
2016 2
2017 6
2018 2
2019 3
2020 5
2021 8
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Neurotrophic keratopathy: current challenges and future prospects.
NaPier E, Camacho M, McDevitt TF, Sweeney AR. NaPier E, et al. Ann Med. 2022 Dec;54(1):666-673. doi: 10.1080/07853890.2022.2045035. Ann Med. 2022. PMID: 35243932 Free PMC article. Review.
Stage 2 treatment can involve therapeutic contact lenses, topical autologous or allogenic serum, tarsorrhaphy, botulinum toxin injections, and possibly anti-inflammatory medications. ...New therapies, such as matrix regenerating therapy, plasma rich in growth factors, Thym …
Stage 2 treatment can involve therapeutic contact lenses, topical autologous or allogenic serum, tarsorrhaphy, botulinum toxin inject …
Acromegaly.
Dineen R, Stewart PM, Sherlock M. Dineen R, et al. QJM. 2017 Jul 1;110(7):411-420. doi: 10.1093/qjmed/hcw004. QJM. 2017. PMID: 26873451 Review.
Acromegaly is a rare, chronic, progressive disease characterized by an excess secretion of growth hormone (GH) and increased circulating insulin-like growth factor 1 (IGF-1) concentrations. It is caused by a pituitary adenoma in the vast majorit …
Acromegaly is a rare, chronic, progressive disease characterized by an excess secretion of growth hormone (GH) and increased circulating …
Insulin-Like Growth Factor (IGF) System in Liver Diseases.
Adamek A, Kasprzak A. Adamek A, et al. Int J Mol Sci. 2018 Apr 27;19(5):1308. doi: 10.3390/ijms19051308. Int J Mol Sci. 2018. PMID: 29702590 Free PMC article. Review.
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors produced in liver. Insulin-like growth factor 1 and 2 (IGF1 and IGF2) act in response to growth hormone (GH). ...In epidemiologic and clinicopathological stu …
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors produced in liver. Insulin-like gro …
Growth hormone.
Bidlingmaier M, Strasburger CJ. Bidlingmaier M, et al. Handb Exp Pharmacol. 2010;(195):187-200. doi: 10.1007/978-3-540-79088-4_8. Handb Exp Pharmacol. 2010. PMID: 20020365 Review.
It acts through binding to the hGH receptor, inducing either direct effects or initiating the production of insulin-like growth-factor I (IGF-I), the most important mediator of hGH effects. ...In this particular group of patients, replacement of …
It acts through binding to the hGH receptor, inducing either direct effects or initiating the production of insulin-like gr …
Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging.
Sonntag WE, Ramsey M, Carter CS. Sonntag WE, et al. Ageing Res Rev. 2005 May;4(2):195-212. doi: 10.1016/j.arr.2005.02.001. Ageing Res Rev. 2005. PMID: 16024298 Review.
IGF-1 crosses the blood-brain barrier and in recent years, much attention has focused on age-related decreases in serum growth hormone and IGF-1 as potential mechanisms that may influence cognitive function in the elderly. ...
IGF-1 crosses the blood-brain barrier and in recent years, much attention has focused on age-related decreases in serum growth …
Cancer in growth hormone excess and growth hormone deficit.
Guevara-Aguirre J, Peña G, Acosta W, Pazmiño G, Saavedra J, Soto L, Lescano D, Guevara A, Gavilanes AWD. Guevara-Aguirre J, et al. Endocr Relat Cancer. 2023 Aug 14;30(10):e220402. doi: 10.1530/ERC-22-0402. Print 2023 Oct 1. Endocr Relat Cancer. 2023. PMID: 37428642 Review.
Along with absent action of GH and IGF-I, ELS individuals also have low serum insulin levels and decreased insulin resistance. Furthermore, hyperglycemia and hyperinsulinemia are indispensable for fast cell mitosis, including that of those cells present in the benig …
Along with absent action of GH and IGF-I, ELS individuals also have low serum insulin levels and decreased insulin resistance. …
The role of insulin-like growth factor 1 and insulin in ageing and atherosclerosis.
Ruiz-Torres A. Ruiz-Torres A. Novartis Found Symp. 2002;242:143-53; discussion 153-60. Novartis Found Symp. 2002. PMID: 11855685 Review.
With advancing age insulin-like growth factor (IGF)1 blood levels decrease continuously, but with great interindividual differences. There is a relationship between the IGF1 serum concentration and biomarker behaviour, indicating that growth hormone (GH) secretion i …
With advancing age insulin-like growth factor (IGF)1 blood levels decrease continuously, but with great interindividual differences. …
The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E epsilon4, Lifestyle Factors, and the Aging Body and Brain.
Galle SA, Geraedts IK, Deijen JB, Milders MV, Drent ML. Galle SA, et al. J Prev Alzheimers Dis. 2020;7(4):265-273. doi: 10.14283/jpad.2020.11. J Prev Alzheimers Dis. 2020. PMID: 32920629 Review.
Aging is associated with a decrease in body and brain function and with a decline in insulin-like growth factor 1 levels. ...We address the impact of age-related decline of insulin-like growth factor 1 l …
Aging is associated with a decrease in body and brain function and with a decline in insulin-like growth fact …
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA).
Hashizume A, Fischbeck KH, Pennuto M, Fratta P, Katsuno M. Hashizume A, et al. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1085-1091. doi: 10.1136/jnnp-2020-322949. J Neurol Neurosurg Psychiatry. 2020. PMID: 32934110 Review.
Evaluation of muscle and fat using MRI, in addition to biochemical indices such as serum creatinine level, are promising biomarkers to track the disease progression. The serum level of creatinine starts to decrease before the onset of muscle weakness, followe …
Evaluation of muscle and fat using MRI, in addition to biochemical indices such as serum creatinine level, are promising biomarkers t …
Retinopathy of prematurity.
Chen J, Smith LE. Chen J, et al. Angiogenesis. 2007;10(2):133-40. doi: 10.1007/s10456-007-9066-0. Epub 2007 Feb 27. Angiogenesis. 2007. PMID: 17332988 Review.
Suppression of VEGF by oxygen in phase I of ROP inhibits normal vessel growth, whereas elevated levels of VEGF induced by hypoxia in phase II of ROP precipitate pathological vessel proliferation. Insulin-like growth factor 1 (IGF-1) is a critica …
Suppression of VEGF by oxygen in phase I of ROP inhibits normal vessel growth, whereas elevated levels of VEGF induced by hypoxia in phase I …
151 results